9 Week Extension Study of Asenapine and Olanzapine in Treatment of Mania (P07007)(COMPLETED)

NCT00143182 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

504

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Asenapine
DRUG: Olanzapine

Sponsor

Organon and Co

Collaborators

[object Object]